Genetic Epidemiology Overview

Principles

Definition

Genetic epidemiology is an academic discipline that investigates the role of genetic factors and their interaction with environmental exposures in the etiology, distribution, and control of diseases in human populations. It employs epidemiological methods to identify and characterize genetic influences on health outcomes, contributing to disease understanding, risk assessment, and the development of targeted interventions.

Ontological type

Core Methods

Study Designs

Key Applications

Key developments

Key Figures

Molecular Integration era

William B. Kannel [1] had affiliations with Harvard University [3] and the University of California, San Francisco [4] during the Molecular Integration era. He advanced molecular epidemiology through the NHLBI Twin Study of Cardiovascular Disease Risk Factors: Methodology and Summary of Results [7], a contribution that helped establish twin designs and genotype–phenotype linkage as central tools for heritability estimation and risk assessment in this era. Steve E. Humphries [2] was affiliated with Washington University in St. Louis [5] and University College London [6] during this era. His work on apolipoprotein B variants included the 1987 Apolipoprotein B gene variants are involved in the determination of serum cholesterol levels: a study in normo- and hypelipidaemic individuals [9] and the 1990 Familial defective apolipoprotein B-100: detection in the United Kingdom and Scandinavia, and clinical characteristics of ten cases [8], translating molecular variation into clinical risk models and helping shape candidate-gene approaches in diagnostic standards.

Association Mapping Consolidation era

Mark J. Daly [1] is associated with Harvard University [3] and the Massachusetts Institute of Technology [4] during this era. His key contributions include PLINK [7], a tool set for whole-genome association and population-based linkage analyses; A Genome-Wide Association Study Identifies <i>IL23R</i> as an Inflammatory Bowel Disease Gene [8]; and Genome-Wide Association Analysis Identifies Loci for Type 2 Diabetes and Triglyceride Levels [9], each advancing scalable, robust association testing and replication standards in this era. Pak C. Sham [2] is linked to University of Cambridge [5] and Erasmus University Rotterdam [6] in this era. His key contribution centers on PLINK [7], a foundational tool enabling scalable GWAS and population-based analyses, which was pivotal to the era's emphasis on rigorous design and reproducibility.

Polygenic Atlas Genomics era

Mark J. Daly [1] is a leading figure in genetic epidemiology during the Polygenic Atlas Genomics era, with affiliations at Rockefeller University [3] and the Harvard–MIT Division of Health Sciences and Technology [4]. In this era he advanced key methods such as LD Score regression [7] to distinguish confounding from polygenicity, contributed to an atlas of genetic correlations across human diseases and traits [8], and introduced estimation of the multiple testing burden for genome-wide association studies of nearly all common variants [9], enabling robust heritability and cross-trait analyses at atlas scale. Paul Flicek [2] has been associated with University of Cambridge [5] and the Swedish University of Agricultural Sciences [6] during this era. His work on genomic annotation and catalogs, notably The Ensembl Variant Effect Predictor [10] and The new NHGRI-EBI Catalog of published genome-wide association studies (GWAS Catalog) [11], consolidated tools and resources that underpin atlas-scale data integration, annotation prioritization, and cross-study replication in polygenic epidemiology [10][11].